These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 38802404)
21. Analysis of population-specific pharmacogenomic variants using next-generation sequencing data. Ahn E; Park T Sci Rep; 2017 Sep; 7(1):8416. PubMed ID: 28871186 [TBL] [Abstract][Full Text] [Related]
22. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing. Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics in the era of next generation sequencing - from byte to bedside. Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459 [TBL] [Abstract][Full Text] [Related]
29. Targeted next generation sequencing as a tool for precision medicine. Gulilat M; Lamb T; Teft WA; Wang J; Dron JS; Robinson JF; Tirona RG; Hegele RA; Kim RB; Schwarz UI BMC Med Genomics; 2019 Jun; 12(1):81. PubMed ID: 31159795 [TBL] [Abstract][Full Text] [Related]
30. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188 [TBL] [Abstract][Full Text] [Related]
31. Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences. Sivadas A; Salleh MZ; Teh LK; Scaria V Pharmacogenomics J; 2017 Oct; 17(5):461-470. PubMed ID: 27241059 [TBL] [Abstract][Full Text] [Related]
32. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043 [TBL] [Abstract][Full Text] [Related]
33. Large-scale integration of heterogeneous pharmacogenomic data for identifying drug mechanism of action. Luo Y; Wang S; Xiao J; Peng J Pac Symp Biocomput; 2018; 23():44-55. PubMed ID: 29218868 [TBL] [Abstract][Full Text] [Related]
34. Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics. Siamoglou S; Koromina M; Hishinuma E; Yamazaki S; Tsermpini EE; Kordou Z; Fukunaga K; Chantratita W; Zhou Y; Lauschke VM; Mushiroda T; Hiratsuka M; Patrinos GP Pharmacol Res; 2022 Feb; 176():106087. PubMed ID: 35033648 [TBL] [Abstract][Full Text] [Related]
36. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations. Al-Mahayri ZN; Patrinos GP; Wattanapokayakit S; Iemwimangsa N; Fukunaga K; Mushiroda T; Chantratita W; Ali BR Sci Rep; 2020 Dec; 10(1):21310. PubMed ID: 33277594 [TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies. Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555 [TBL] [Abstract][Full Text] [Related]
38. Individualizing pharmacogenomic test results in the context of the microbiome. Haga SB Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284 [TBL] [Abstract][Full Text] [Related]